New hepatitis b blood tests put to the test on 21,000 samples
NCT ID NCT04904835
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study checked how well new blood tests (Access HBV assays) can detect hepatitis B infection. Researchers tested over 21,000 leftover blood samples from adults, including blood donors and hospital patients. The goal was to see if these tests are accurate compared to existing approved tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Access HBV serological marker assays (blood tests for hepatitis B)
What this could lead to
If successful, these tests could provide a reliable way to diagnose hepatitis B infection, helping doctors identify and manage the disease.
What could go wrong
This is a diagnostic accuracy study, not a treatment trial. The tests may not perform equally well in all populations or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HBV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre de Ressources Biologiques Biobanque de Picardie CHU Amiens-Picardie
Amiens, 80054, France
-
Cerba Xpert
Frépillon, 95740, France
-
Etablissement Français du Sang (EFS) Hauts-de-France - Normandie
Bois-Guillaume, 76232, France
-
Eurofins Biomnis
Ivry-sur-Seine, 94208, France
-
Laboratoire de Virologie, Laboratoire associé au CNR du VIH Institut de Biologie Clinique ; hôpital C : Nicolle, CHU Rouen
Rouen, 76031, France